Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6610 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2024-01-16 (livingfit.co.za)
Biogen first SA brand to launch Informed-Sport certified premium pre-workout for athletes - Dis-Chem Living Fit
Biogen has launched the first Informed-Sport certified premium pre-workout for athletes.
Read more
2023-11-08 (marketwatch.com)
Biogen quarterly results top estimates despite complex launch of new Alzheimer's treatment
Company focuses on new products in Alzheimer's, postpartum depression as multiple sclerosis product revenues decline
Read more
2023-08-23 (e-fundresearch.com)
Lord Abbett Convertible A USD Acc | IE000RG4BZ88 | e-fundresearch.com
Fund rankings & insights - Lord Abbett Convertible A USD Acc (IE000RG4BZ88) - Lord Abbett (Ireland) Ltd - other convertible bond funds and global convertible bonds (USD-hedged) funds in the fund ranking on e-fundresearch.com
Read more
(asahi.com)
Alzheimer’s drug lecanemab set to soon be approved for use in Japan | The Asahi Shimbun: Breaking News, Japan News and Analysis
A medication that could help treat early stages of Alzheimer's disease is on track to be approved for manufacturing and sales in Japan after being endorsed by a health ministry expert panel on Aug. 21.
Read more